secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2025-05-13T23:59:59+00:00
Accession:  0001641172-25-009941
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma appoints two new directors; two resign; board reduced to four
--------------------------------------------------------------------------

- Board increased from 4 to 6 on May 7; Hilary Kramer appointed as non-employee director.
- Bruce Wendel resigned from Board and all committees on May 7.
- Andrew Ritter appointed as non-employee director on May 8.
- Rajesh Shrotriya resigned from Board and all committees on May 12.
- Board reduced to 4 members; Kramer chairs Nominating Committee, Ritter chairs Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000164117225009941/0001641172-25-009941-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000164117225009941/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-009941

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer